Search Tag: ECCMID 2019
2019 10 Apr
Data will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panels—positively impact patients with bloodstream infections. LEXINGTON, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development of innovative medical diagnostic products...Read more